argenx SE (EBR:ARGX)
Belgium · Delayed Price · Currency is EUR 709.20
-18.80 (-2.58%)
Oct 22, 2025, 5:35 PM CET
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
€1,661,901
Profits / Employee
€681,838
Market Cap
43.40B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,599 | 451 | 39.29% |
| Dec 31, 2023 | 1,148 | 305 | 36.18% |
| Dec 31, 2022 | 843 | 193 | 29.69% |
| Dec 31, 2021 | 650 | 314 | 93.45% |
| Dec 31, 2020 | 336 | 150 | 80.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UCB SA | 9,378 |
| Fagron NV | 3,828 |
| Ion Beam Applications | 2,287 |
| Nyxoah | 184 |
| European Medical Solutions | 122 |
| Onward Medical | 103 |
| Hyloris Pharmaceuticals | 49 |
| Sequana Medical NV | 48 |
argenx SE News
- 5 days ago - argenx Reaches Analyst Target Price - Nasdaq
- 7 days ago - argenx to Highlight Key Data and Breadth of Immunology Innovation at 2025 AANEM Annual Meeting and MGFA Scientific Session - GlobeNewsWire
- 9 days ago - How Do Investors Really Feel About argenx SE? - Benzinga
- 9 days ago - Wedbush Raises Price Target for ARGX, Maintains Outperform Rating | ARGX Stock News - GuruFocus
- 19 days ago - argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025 - GlobeNewsWire
- 21 days ago - Morgan Stanley Raises Price Target for ARGX to $1040 While Maintaining Overweight Rating | ARGX ... - GuruFocus
- 22 days ago - INCY vs. ARGX: Which Stock Is the Better Value Option? - Nasdaq
- 23 days ago - Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today - Benzinga